4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.

Matulenko, Mark A; Paight, Ernest S; Frey, Robin R; Gomtsyan, Arthur; DiDomenico, Stanley; Jiang, Meiqun; Lee, Chih-Hung; Stewart, Andrew O; Yu, Haixia; Kohlhaas, Kathy L; Alexander, Karen M; McGaraughty, Steve; Mikusa, Joseph; Marsh, Kennan C; Muchmore, Steven W; Jakob, Clarissa L; Kowaluk, Elizabeth A; Jarvis, Michael F; Bhagwat, Shripad S

Matulenko, Mark A; Paight, Ernest S; Frey, Robin R; Gomtsyan, Arthur; DiDomenico, Stanley; Jiang, Meiqun; Lee, Chih-Hung; Stewart, Andrew O; Yu, Haixia; Kohlhaas, Kathy L; Alexander, Karen M; McGaraughty, Steve; Mikusa, Joseph; Marsh, Kennan C; Muchmore, Steven W; Jakob, Clarissa L; Kowaluk, Elizabeth A; Jarvis, Michael F; Bhagwat, Shripad S.

Affiliation

Matulenko MA; Neuroscience Research, Global Pharmaceutical Research Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. mark.a.matulenko@abbott.com

Bioorg Med Chem ; 15(4): 1586-605, 2007 Feb 15.

Article in En | MEDLINE | ID: mdl-17197188

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Adenosine Kinase Limits: Animals Language: En Journal: Bioorg Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2007 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links